| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 886 | 2021 |
| The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 PG Thomas, P Dash, JR Aldridge, AH Ellebedy, C Reynolds, AJ Funk, ... Immunity 30 (4), 566-575, 2009 | 804 | 2009 |
| Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Z Liu, LA VanBlargan, LM Bloyet, PW Rothlauf, RE Chen, S Stumpf, ... Cell host & microbe 29 (3), 477-488. e4, 2021 | 708 | 2021 |
| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 658 | 2021 |
| SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans JS Turner, W Kim, E Kalaidina, CW Goss, AM Rauseo, AJ Schmitz, ... Nature 595 (7867), 421-425, 2021 | 532 | 2021 |
| A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ... Cell 182 (3), 744-753. e4, 2020 | 515 | 2020 |
| Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination AH Ellebedy, KJL Jackson, HT Kissick, HI Nakaya, CW Davis, KM Roskin, ... Nature immunology 17 (10), 1226-1234, 2016 | 385 | 2016 |
| Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections KE Remy, M Mazer, DA Striker, AH Ellebedy, AH Walton, J Unsinger, ... JCI insight 5 (17), 2020 | 317 | 2020 |
| Human Ebola virus infection results in substantial immune activation AK McElroy, RS Akondy, CW Davis, AH Ellebedy, AK Mehta, CS Kraft, ... Proceedings of the National Academy of Sciences 112 (15), 4719-4724, 2015 | 311 | 2015 |
| Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ... Annals of internal medicine 174 (11), 1572-1585, 2021 | 278 | 2021 |
| SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 F Amanat, M Thapa, T Lei, SMS Ahmed, DC Adelsberg, JM Carreño, ... Cell 184 (15), 3936-3948. e10, 2021 | 243 | 2021 |
| Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans AH Ellebedy, F Krammer, GM Li, MS Miller, C Chiu, J Wrammert, ... Proceedings of the National Academy of Sciences 111 (36), 13133-13138, 2014 | 232 | 2014 |
| Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ... Science advances 6 (50), eabe3024, 2020 | 223 | 2020 |
| Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season SL Linderman, BS Chambers, SJ Zost, K Parkhouse, Y Li, C Herrmann, ... Proceedings of the National Academy of Sciences 111 (44), 15798-15803, 2014 | 221 | 2014 |
| In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 217 | 2021 |
| Human germinal centres engage memory and naive B cells after influenza vaccination JS Turner, JQ Zhou, J Han, AJ Schmitz, AA Rizk, WB Alsoussi, T Lei, ... Nature 586 (7827), 127-132, 2020 | 211 | 2020 |
| Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 205 | 2022 |
| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 199 | 2022 |
| Broadly protective human antibodies that target the active site of influenza virus neuraminidase D Stadlbauer, X Zhu, M McMahon, JS Turner, TJ Wohlbold, AJ Schmitz, ... Science 366 (6464), 499-504, 2019 | 189 | 2019 |
| A potently neutralizing antibody protects mice against SARS-CoV-2 infection WB Alsoussi, JS Turner, JB Case, H Zhao, AJ Schmitz, JQ Zhou, RE Chen, ... The Journal of Immunology 205 (4), 915-922, 2020 | 180 | 2020 |
